Department of Psychiatry

Workshop Descriptions – Depression Guidelines 2016 & Psychopharmacology Update Conference

Dr. Glenda MacQueen
Morning Plenary – Treating Depression in Specific Populations: Lifespan and Gender Perspectives


Dr. Ayal Schaffer
Morning Plenary – Data Famine to Data Feast: Shaping Treatment Options for Bipolar Depression
This presentation will examine the importance of diagnostic specificity in the management of depression and review updated treatment data for bipolar depression


Dr. Raymond Lam
Workshop #1 – Cognitive Screening in Depressed Patients
This workshop focuses on brief cognitive screening using validated subjective and objective measures, including a demonstration of THINC-it, a new cognitive screening tool designed for clinical settings.


Dr. Peter Giacobbe & Dr. Roumen Milev
Workshop #2 – Delivering Neurostimulation Therapies in Ontario
This workshop focuses on brain stimulation approaches for the treatment of Major Depressive Disorder. At the completion of the workshop, participants will be able to list the evidence for the acute antidepressant efficacy, relapse prevention properties, side-effect profiles, accessibility and the clinical recommendations for brain stimulation approaches from the 2016 CANMAT guidelines.


Dr. Glenda MacQueen
Workshop #3 – Practical Issues in Managing Adolescent Depression
This workshop will challenge common myths in the treatment of adolescent depression. Diagnosis and common co-morbidities will be discussed in addition to the evidence for treatment options, including self-care, psychotherapy and pharmacotherapy.


Dr. Sagar Parikh
Workshop #4 – Psychotherapy and Pharmacotherapy in Clinical Practice
This workshop will cover when and how to combine strategies; when and how to use internet-based psychotherapy to augment medication; how to use the key aspects of the therapeutic alliance (as understood from psychotherapy research) to enhance medication compliance, and to do all this via discussion of patient cases.  Participants will be encouraged to share patient scenarios for discussion.


Dr. Sidney Kennedy
Afternoon Plenary – Canadian Biomarker Integration Network in Depression (CANBIND): Are we making progress?


Dr. Christopher Bowie
Assessing Cognitive Difficulties in Daily Life
Cognitive impairments are increasingly recognized as a critical barrier to full functional recovery in depressive disorders. As pharmacological and psychological treatments emerge with more promise for enhancing cognition, clinicians will benefit from knowing how to recognize, assess, and discuss cognition and its role in functioning. The purposes of this presentation are to characterize cognitive impairment in depression, review existing and emerging methods for measuring cognition, and discuss how cognitive impairments manifest in daily life.


Dr. Aristotle Voineskos
Morning Plenary – Early Intervention for Psychosis
This presentation will review the latest evidence regarding comprehensive approaches to care in first episode psychosis. It will also introduce ongoing research initiatives aimed at transforming clinical care in this population.


Dr. Jim Kennedy
Morning Plenary – Pharmacogenetic Testing is Replacing Trial-and-Error Prescribing


Dr. Gary Remington
Workshop #1 – Advances in Psychopharmacology in Schizophrenia
Treatments will be discussed as a function of the various symptom domains and results to date. In addition, shifts in treatment that reflect changes in how we conceptualize schizophrenia will also be reviewed.


Dr. Peggy  Richter
Workshop #2 – Treatment Updates in OCD
This workshop will focus on providing participants with up-to-date information regarding best practice in the pharmacological treatment of OCD.  Differences in approach for the OCD Related Disorders such as Hoarding Disorder will also be introduced.


Dr. Ben Goldstein

Workshop #3 – Updates in Adolescent Bipolar Disorder
This presentation will provide a critical overview of the current literature regarding the treatment of bipolar disorder in adolescents, and will offer future directions for continued research. Psychiatric and physical comorbidity will also be addressed in relation to prevention and intervention approaches


Dr. Andriy Samokhvalov
Workshop #4 – Treating Co-Morbid Alcohol Use and Mood Disorders
This workshop will focus on treatment of concurrent alcohol use disorder and mood disorders, primarily – major depressive disorder. During the workshop tailoring pharmacotherapy and integrating it with psychotherapy for alcohol use disorder and concurrent major disorder will be discussed.  Also, the practical aspects of implementation of integrated treatments for concurrent disorders will be outlined and illustrated with the data from a large multi-site provincial project.


Dr. Simone Vigod
Afternoon Plenary – Perinatal Psychiatry
About 20% of women suffer from a mental illness around the time of pregnancy.  Mental illnesses can onset prior to or in pregnancy, or manifest for the first time postnatally, where presentations are among some of the most severe forms of illness in psychiatry. Untreated or undertreated, perinatal mental illness can have substantial negative impact on a mother’s health and well-being, and the health and development of her child.  This plenary session will include a review of the safety and efficacy of pharmacological treatments for mental illness in pregnancy and lactation to help guide prescribing recommendations around the time of pregnancy.


Dr. Tarek Rajji
Workshop #5 – Managing Behavioural and Psychiatric Symptoms in Neurocognitive Disorders
This workshop will focus on the development and implementation of an integrated care pathway to treat agitation and aggression in dementia on an inpatient unit.


Dr. David Gratzer
Workshop #6 – Integrating Online Psychotherapies into Clinical Practice
In this interactive workshop, Dr. David Gratzer and several e-therapists from The Scarborough Hospital will discuss apps and e-therapies (iCBT and iMindfulness). The discussion will be practical, including a consideration of apps that can be incorporated into clinical practice.


Dr. Susan Abbey
Workshop #7 – Treatment of Somatization
This workshop will review what is documented in the literature about the impact of psychopharmacology in the management of somatic symptom disorders as well as the “art” of using medications in these patients.


Dr. Andriy Samokhvalov
Workshop #8 – Treating Co-Morbid Alcohol Use and Mood Disorders
This workshop will focus on treatment of concurrent alcohol use disorder and mood disorders, primarily – major depressive disorder. During the workshop tailoring pharmacotherapy and integrating it with psychotherapy for alcohol use disorder and concurrent major disorder will be discussed.  Also, the practical aspects of implementation of integrated treatments for concurrent disorders will be outlined and illustrated with the data from a large multi-site provincial project.


Dr. Andrea Waddell and Dr. Nadiya Sunderji
Skill-Based Workshop* (Section 3) – Medication Monitoring in Practice
Peer feedback on your practice can be invaluable in helping you to identify opportunities for change.  This facilitated group session will provide a chance to review the results of your own practice audit and brainstorm approaches to increase adherence to monitoring guidelines.